A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.

MLA

Schömig, Albert, et al. “A Meta-Analysis of 16 Randomized Trials of Sirolimus-Eluting Stents versus Paclitaxel-Eluting Stents in Patients with Coronary Artery Disease.” Journal of the American College of Cardiology, vol. 50, no. 14, Oct. 2007, pp. 1373–80. EBSCOhost, https://doi.org/10.1016/j.jacc.2007.06.047.

APA

Schömig, A., Dibra, A., Windecker, S., Mehilli, J., Suárez de Lezo, J., Kaiser, C., Park, S.-J., Goy, J.-J., Lee, J.-H., Di Lorenzo, E., Wu, J., Jüni, P., Pfisterer, M. E., Meier, B., & Kastrati, A. (2007). A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. Journal of the American College of Cardiology, 50(14), 1373–1380. https://doi.org/10.1016/j.jacc.2007.06.047

Chicago

Schömig, Albert, Alban Dibra, Stephan Windecker, Julinda Mehilli, José Suárez de Lezo, Christoph Kaiser, Seung-Jung Park, et al. 2007. “A Meta-Analysis of 16 Randomized Trials of Sirolimus-Eluting Stents versus Paclitaxel-Eluting Stents in Patients with Coronary Artery Disease.” Journal of the American College of Cardiology 50 (14): 1373–80. doi:10.1016/j.jacc.2007.06.047.